LRI Investments LLC Has $51,000 Position in GE HealthCare Technologies Inc. (NASDAQ:GEHC)

LRI Investments LLC increased its position in GE HealthCare Technologies Inc. (NASDAQ:GEHC) by 176.9% in the 4th quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The firm owned 648 shares of the company’s stock after buying an additional 414 shares during the quarter. LRI Investments LLC’s holdings in GE HealthCare Technologies were worth $51,000 as of its most recent filing with the Securities and Exchange Commission (SEC).

Other institutional investors and hedge funds also recently made changes to their positions in the company. CoreFirst Bank & Trust acquired a new position in shares of GE HealthCare Technologies in the fourth quarter valued at approximately $25,000. Runnymede Capital Advisors Inc. acquired a new position in shares of GE HealthCare Technologies in the fourth quarter valued at approximately $28,000. LGT Financial Advisors LLC increased its stake in shares of GE HealthCare Technologies by 46.2% in the fourth quarter. LGT Financial Advisors LLC now owns 389 shares of the company’s stock valued at $30,000 after buying an additional 123 shares during the period. Accredited Wealth Management LLC acquired a new position in shares of GE HealthCare Technologies in the fourth quarter valued at approximately $30,000. Finally, Bank of Jackson Hole Trust acquired a new position in shares of GE HealthCare Technologies in the fourth quarter valued at approximately $32,000. Institutional investors and hedge funds own 82.06% of the company’s stock.

GE HealthCare Technologies Price Performance

GE HealthCare Technologies stock opened at $73.83 on Wednesday. The stock has a market capitalization of $33.81 billion, a price-to-earnings ratio of 17.05, a PEG ratio of 3.19 and a beta of 1.21. GE HealthCare Technologies Inc. has a 52-week low of $57.65 and a 52-week high of $94.80. The stock’s 50 day moving average price is $72.05 and its two-hundred day moving average price is $80.44. The company has a debt-to-equity ratio of 0.88, a quick ratio of 0.83 and a current ratio of 1.04.

GE HealthCare Technologies (NASDAQ:GEHC) last posted its quarterly earnings results on Wednesday, April 30th. The company reported $1.01 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $0.91 by $0.10. The firm had revenue of $4.78 billion for the quarter, compared to analysts’ expectations of $4.66 billion. GE HealthCare Technologies had a return on equity of 25.74% and a net margin of 10.13%. The company’s revenue for the quarter was up 2.7% compared to the same quarter last year. During the same period in the prior year, the business earned $0.90 EPS. On average, equities analysts predict that GE HealthCare Technologies Inc. will post 4.68 earnings per share for the current year.

GE HealthCare Technologies declared that its Board of Directors has initiated a share repurchase program on Wednesday, April 30th that permits the company to repurchase $1.00 billion in outstanding shares. This repurchase authorization permits the company to purchase up to 3.1% of its stock through open market purchases. Stock repurchase programs are generally an indication that the company’s leadership believes its shares are undervalued.

GE HealthCare Technologies Dividend Announcement

The company also recently announced a quarterly dividend, which will be paid on Thursday, May 15th. Investors of record on Friday, April 25th will be issued a $0.035 dividend. This represents a $0.14 dividend on an annualized basis and a dividend yield of 0.19%. The ex-dividend date is Friday, April 25th. GE HealthCare Technologies’s dividend payout ratio is currently 2.95%.

Wall Street Analysts Forecast Growth

Several research analysts have recently issued reports on GEHC shares. Piper Sandler lowered their price objective on GE HealthCare Technologies from $104.00 to $88.00 and set an “overweight” rating for the company in a research note on Wednesday, April 23rd. The Goldman Sachs Group decreased their target price on shares of GE HealthCare Technologies from $94.00 to $82.00 and set a “buy” rating for the company in a research report on Thursday, May 1st. Evercore ISI decreased their target price on shares of GE HealthCare Technologies from $96.00 to $85.00 and set an “outperform” rating for the company in a research report on Thursday, May 1st. Wells Fargo & Company decreased their target price on shares of GE HealthCare Technologies from $103.00 to $89.00 and set an “overweight” rating for the company in a research report on Thursday, May 1st. Finally, BTIG Research set a $95.00 target price on shares of GE HealthCare Technologies and gave the company a “buy” rating in a research report on Monday, April 14th. Three equities research analysts have rated the stock with a hold rating, eight have issued a buy rating and one has given a strong buy rating to the stock. Based on data from MarketBeat, the company presently has a consensus rating of “Moderate Buy” and a consensus target price of $88.27.

About GE HealthCare Technologies

GE HealthCare Technologies Inc engages in the development, manufacture, and marketing of products, services, and complementary digital solutions used in the diagnosis, treatment, and monitoring of patients in the United States, Canada, and internationally. The company operates through four segments: Imaging, Ultrasound, Patient Care Solutions, and Pharmaceutical Diagnostics.